Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) : an atypical case during treatment with sulfasalazine
Famularo, G.; Bravi, M.C.; Gasbarrone, L.; Minisola, G.
Clinical and Experimental Rheumatology 31(2): 326-327
2013
ISSN/ISBN: 0392-856X PMID: 23406887 Document Number: 666859
Document emailed within 1 workday
Related Documents
Lian, B.Sy.; Busmanis, I.; Lee, H.Yueh. 2018: Relapsing Course of Sulfasalazine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Alopecia Universalis and Vitiligo Annals of the Academy of Medicine Singapore 47(11): 492-493Salame, N.; Chow, M.L..; Ochoa, M.T..; Compoginis, G.; Crew, A.B.. 2019: Sorafenib Toxicity Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Journal of Drugs in Dermatology: Jdd 18(5): 468-469
Antia, C.; Persad, L.; Alikhan, A. 2017: Trimethoprim-Sulfamethoxazole-Induced Drug Eruption with Eosinophilia and Systemic Symptoms (DRESS) Journal of Drugs in Dermatology: Jdd 16(10): 1043-1046
Fernández de Córdova-Rodríguez1, L.R.é; Guzmán-Guillén, K.A.; Fernández de Córdova-Aguirre, J.C. 2015: DRESS syndrome or reaction to drugs with eosinophilia and systemic symptoms associated to anti-tuberculosis drugs Revista Alergia Mexico 62(2): 149-156
Patel, A.; Patro, S.; Mishra, S.; Patel, A. 2020: Autoimmune Type 1 Diabetes Mellitus and Autoimmune Thyroiditis - a rare sequelae of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Journal of the Association of Physicians of India 68(1): 50
Van der Mark, S.C.; Segers, D.; Bakker, R.é C.; van Wijngaarden, P. 2010: DRESS syndrome as a result of sulfasalazine use Nederlands Tijdschrift Voor Geneeskunde 154(18): A2161
Rebrov, V.G.; Lukomskiĭ, M.I. 1989: A case of depression in the treatment of nonspecific ulcerative colitis with sulfasalazine Klinicheskaia Meditsina 67(8): 106
Persson, M.; Svenberg, T.; Poppen, B. 1995: To dress or not to dress surgical wounds? Patients' attitudes to wound care after major abdominal operations European Journal of Surgery 161(11): 791
Sotolongo, R.P.; Neefe, L.I.; Rudzki, C.; Ishak, K.G. 1978: Hypersensitivity reaction to sulfasalazine with severe hepatotoxicity Gastroenterology 75(1): 95-99
Gordon, B.L.; Keenan, J.P. 1975: The treatment of systemic lupus erythematosus (SLE) with the T-cell immunostimulant drug levamisole: A case report Annals of Allergy 35(6): 343-355
Bedi, R.S. 1991: Atypical radiological presentation of tropical pulmonary eosinophilia Indian Journal of Chest Diseases and Allied Sciences 33(2): 97-99
Saito, T.; Isozumi, K.; Komatsumoto, S.; Nara, M.; Suzuki, K.; Dohura, K. 2000: A case of codon 232 mutation-induced Creutzfeldt-Jakob disease visualized by the MRI-FLAIR images with atypical clinical symptoms Rinsho Shinkeigaku 40(1): 51-54
Korthals-de Bos, I.; Van Tulder, M.; Boers, M.; Verhoeven, A.C.; Adèr, H.J.; Bibo, J.; Boonen, A.; Van Der Linden, S. 2004: Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone Journal of Rheumatology 31(9): 1709-1716
Teja, B.R.; S, L.; Swaapnikavemulapalli 2020: A case of DRESS syndrome Journal of the Association of Physicians of India 68(1): 105
Parab, P.B.; Samuel, A.M.; Udwadia, F.E.; Ganatra, R.D. 1979: Hypersensitivity reaction in tropical eosinophilia Indian Journal of Medical Research 69: 122-127
Patel, S.; Raut, I.; Ram, R.P. 2020: A rare case of DRESS syndrome Journal of the Association of Physicians of India 68(1): 79
Takasugi, K. 1973: Case of systemic subcutaneous nodule formation, polyneuritis, temporal arteritis, melena and other symptoms associated with an eosinophilic state Ryumachi 13(4): 416-418
Taylor, D. 2001: Atypical antipsychotics in the treatment of schizophrenia. Pragmatic considerations are important when considering which drug to prescribe Bmj 322(7291): 925; Author Reply 927-8
Paitorn, L. 2016: Co-Trimoxazole-Induced DRESS Syndrome: A Case Report Journal of the Medical Association of Thailand 99 Suppl. 2: S227-S230
Kupriyanov, Y.A.; Rasner, P.I.; Rokhlikov, I.M.; Akrikidi, A.A.; Soloviev, V.V.; Markov, A.A.; Nozdrin, E.V.; Logvinov, L.A.; Vasilevskiy, R.P.; Skrupskiy, K.S.; Pushkar, D.Y.; Putilovskiy, M.A.; Epstein, O.I. 2019: The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-nave patients with benign prostatic hyperplasia Urologiia 3: 36-42